Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0I6AU
|
||||
| Former ID |
DIB012628
|
||||
| Drug Name |
BDD-10103
|
||||
| Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Phase 1 | [550380] | ||
| Company |
Berolina Innovative Research and Development Services Pharma AG
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Modulator | [550379] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.